Page 80 - 《中国药科大学学报》2025年第5期
P. 80

612                      学报   Journal of China Pharmaceutical University 2025, 56(5): 601 − 612  第 56 卷

                    Engl J Med, 2013, 369(9): 840-851.               14(1): 4895.
               [4]   Souza  ACP,  Yuen  PST,  Star  RA.  Microparticles:  markers  and  [11]   Zhang C, Yang ZW, Zhou P, et al. Phosphatidylserine-expos-
                    mediators  of  sepsis-induced microvascular  dysfunction,   im-  ing  tumor-derived  microparticles  exacerbate  coagulation  and
                    munosuppression, and AKI[J]. Kidney Int, 2015, 87(6): 1100-1108.  cancer  cell  transendothelial  migration  in  triple-negative  breast
               [5]   Ewees MGE, Abdel-Bakky MS, Bayoumi AMA, et al. Dabiga-  cancer[J]. Theranostics, 2021, 11(13): 6445-6460.
                    tran  mitigates  cisplatin-mediated  nephrotoxicity  through  down  [12]   Yang X, Jia RM, Hu F, et al. Promoting AMPK/SR-A1-mediat-
                    regulation of thrombin pathway[J]. J Adv Res, 2021, 31: 127-  ed clearance of HMGB1 attenuates chemotherapy-induced pe-
                    136.                                             ripheral neuropathy[J]. Cell Commun Signal, 2023, 21(1): 99.
               [6]   Delgado-Rizo  V,  Martínez-Guzmán  MA,  Iñiguez-Gutierrez  L,  [13]   Wang L, Chen ZY, Liu Y, et al. Ozone oxidative postcondition-
                    et  al.  Neutrophil extracellular  traps  and  its  implications  in   in-  ing inhibits oxidative stress and apoptosis in renal ischemia and
                    flammation: an overview[J]. Front Immunol, 2017, 8: 81.  reperfusion injury through inhibition of MAPK signaling path-
               [7]   He J, Zheng F, Qiu LH, et al. Plasma neutrophil extracellular  way[J]. Drug Des Devel Ther, 2018, 12: 1293-1301.
                    traps in patients with sepsis-induced acute kidney injury serve  [14]   Wang YH, Mi Y, Tian JH, et al. Intermedin alleviates renal is-
                    as a new biomarker to predict 28-day survival outcomes of dis-  chemia-reperfusion  injury  and  enhances  neovascularization  in
                    ease[J]. Front Med (Lausanne), 2024, 11: 1496966.  wistar rats[J]. Drug Des Devel Ther, 2020, 14: 4825-4834.
               [8]   Frangou E, Chrysanthopoulou A, Mitsios A, et al. REDD1/au-  [15]   Palygin O, Ilatovskaya DV, Staruschenko A. Protease-activated
                    tophagy pathway promotes thromboinflammation and fibrosis in  receptors in kidney disease progression[J]. Am J Physiol Renal
                    human systemic lupus erythematosus (SLE) through NETs dec-  Physiol, 2016, 311(6): F1140-F1144.
                                                                                               -
                                                                                                          +
                    orated with tissue factor (TF) and interleukin-17A (IL-17A)[J].  [16]   Chen YY, Liu J, Su Y, et al. Annexin V  and tissue factor   mi-
                    Ann Rheum Dis, 2019, 78(2): 238-248.             croparticles as biomarkers for predicting deep vein thrombosis
               [9]   Yan CX, Zhang Y, Jin L, et al. Medical ozone alleviates acute  in  patients  after  joint  arthroplasty[J].  Clin  Chim  Acta,  2022,
                    lung  injury  by  enhancing  phagocytosis  targeting  NETs  via  536: 169-179.
                    AMPK/SR-A1 axis[J]. J Biomed Res, 2024, 38(6): 1-16.  [17]   Ohnishi  K,  Komohara  Y,  Fujiwara  Y,  et  al.  Suppression  of
               [10]   Onyishi CU, Desanti GE, Wilkinson AL, et al. Toll-like recep-  TLR4-mediated inflammatory response by macrophage class A
                    tor 4 and macrophage scavenger receptor 1 crosstalk regulates  scavenger receptor (CD204)[J]. Biochem Biophys Res Commun,
                    phagocytosis  of  a  fungal  pathogen[J].  Nat  Commun,  2023,  2011, 411(3): 516-522.

               ·本刊讯·




                               《中国药科大学学报》继续入选中国科学引文
                                              数据库(CSCD)核心库



                     近日,中国科学院文献情报中心公布了中国科学引文数据库(Chinese Science Citation Database,简称                  CSCD)
                 2025—2026  年度来源期刊遴选结果,《中国药科大学学报》继续入选核心库!
                     CSCD  来源期刊每两年遴选一次。每次遴选均采用定量与定性相结合的方法。2025—2026                         年度   CSCD  收录来
                 源期刊   1 464  种,其中,中文期刊    1 046  种,英文期刊  418  种。CSCD  来源期刊分为核心库和扩展库,其中核心库             1 098
                 种,扩展库    366  种。
                     本刊再次成功入选 CSCD       核心库。这一成绩,凝聚了广大作者的辛勤付出、审稿专家的严谨把关、编委团队的
                 专业指导,以及读者朋友们一如既往的信任与支持。值此,编辑部谨向所有关心和支持本刊发展的同仁致以衷心的
                 感谢!

                                                                                               (本刊编辑部)
   75   76   77   78   79   80   81   82   83   84   85